Abstract
To design and synthesize novel pyrazole-linked norcanthridin analogs and their disodium phosphates by [3+2]1, 3-dipolar cycloaddition reaction of norcantharidin derivatives of substituted aromatic amines with three hydrazines. All analogues have been screened for their antiproliferative activity in vitro against a panel of tumor cell lines: KB, SMMC-7721, SGC7901, ECA109, HO-8910, K562, A549 and MCF-7 producing IC50 values from 0.07 μM to > 100 μM. Compound 8c showed potency for the treatment of hepatoma, with IC50 value to SMMC-7721 cell line comparable to that of norcantharidin. High potency and selectivity of compound 12 to MCF-7 cell line prove that the phosphorylation of norcantharidin analogs is an effective way to increase the activity and solubility.
Keywords: Pyrazole-linked, Norcantharidin analogs, Cycloadddition, Disodium phosphate, Anticancer evaluation, Solubility
Letters in Drug Design & Discovery
Title: Disodium Phosphate of Novel Pyrazole-Linked Norcantharidin Analogs:Design, Synthesis and their Anticancer Evaluation
Volume: 5 Issue: 5
Author(s): Liping Deng, Bo Yang, Qiaojun He and Yongzhou Hu
Affiliation:
Keywords: Pyrazole-linked, Norcantharidin analogs, Cycloadddition, Disodium phosphate, Anticancer evaluation, Solubility
Abstract: To design and synthesize novel pyrazole-linked norcanthridin analogs and their disodium phosphates by [3+2]1, 3-dipolar cycloaddition reaction of norcantharidin derivatives of substituted aromatic amines with three hydrazines. All analogues have been screened for their antiproliferative activity in vitro against a panel of tumor cell lines: KB, SMMC-7721, SGC7901, ECA109, HO-8910, K562, A549 and MCF-7 producing IC50 values from 0.07 μM to > 100 μM. Compound 8c showed potency for the treatment of hepatoma, with IC50 value to SMMC-7721 cell line comparable to that of norcantharidin. High potency and selectivity of compound 12 to MCF-7 cell line prove that the phosphorylation of norcantharidin analogs is an effective way to increase the activity and solubility.
Export Options
About this article
Cite this article as:
Deng Liping, Yang Bo, He Qiaojun and Hu Yongzhou, Disodium Phosphate of Novel Pyrazole-Linked Norcantharidin Analogs:Design, Synthesis and their Anticancer Evaluation, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912054
DOI https://dx.doi.org/10.2174/157018008784912054 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized Medicine
Current Molecular Medicine Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge
Current Signal Transduction Therapy Fragment-Based Discovery of Inhibitors of Protein Kinase B
Current Topics in Medicinal Chemistry Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Current Pharmaceutical Design Pulmonary Arterial Hypertension
Current Vascular Pharmacology Cellular Targets for Anticancer Strategies
Current Drug Targets Therapeutic Potential of Peptide Toxins that Target Ion Channels
Inflammation & Allergy - Drug Targets (Discontinued) Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery The Role of SHP-2 in Cell Signalling and Human Disease
Current Enzyme Inhibition Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway
Current Neurovascular Research A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Letters in Organic Chemistry Resveratrol in Cancer: Cellular and Mitochondrial Consequences of Proton Transport Inhibition
Current Pharmaceutical Design A Homodimer Model Can Resolve the Conundrum as to How Cytochrome P450 Oxidoreductase and Cytochrome b5 Compete for the Same Binding Site on Cytochrome P450c17
Current Protein & Peptide Science